Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-25T08:04:21.424Z Has data issue: false hasContentIssue false

Chapter 22 - Ovulation Induction for Hypogonadotropic Hypogonadism

from Section 4 - Non-conventional Forms Used during Ovarian Stimulation

Published online by Cambridge University Press:  14 April 2022

By
Lina El-Taha ,
Botros Rizk ,
Chantal Farra  and
Johnny Awwad
Edited by
Mohamed Aboulghar  and
Botros Rizk
Mohamed Aboulghar
Affiliation:
University of Cairo IVF Centre
Botros Rizk
Affiliation:
University of South Alabama
Get access

Summary

Reproduction in humans is contingent upon the pulsatile secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus. This neuroendocrine activity results in the production and release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and is essential therefore for proper steroidogenesis and gametogenesis within gonads.

Type
Chapter
Information
Ovarian Stimulation , pp. 208 - 222
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

The Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 2008;90:S219–S225.Google Scholar
Bulun, SE, Adashi, EY. The physiology and pathology of the female reproductive axis. In: Melmed, S, Polonsky, KS, Larsen, PR, Kronenberg, HM, eds. Williams Textbook of Endocrinology, 13th ed. Philadelphia: Elsevier Health Sciences; 2015:590–663.Google Scholar
Fevold, HL. Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology 1941;28:33–36.CrossRefGoogle Scholar
Richards, JS. Hormonal control of gene expression in the ovary. Endocr Rev 1994;15:725–751.Google Scholar
Erickson, GF, Magoffin, DA, Dyer, CA, Hofeditz, C. The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 1985;6:371–399.Google Scholar
Angelopoulos, N, Goula, A, Tolis, G. The role of luteinizing hormone activity in controlled ovarian stimulation. J Endocrinol Invest 2005;28:79–88.CrossRefGoogle ScholarPubMed
European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998;83:1507–1514.Google Scholar
Lunenfeld, B. Historical perspectives in gonadotrophin therapy. Hum Reprod Update 2004;10:453–467.Google Scholar
Rowe, PJ, Comhaire, FH, Hargreave, TB, et al. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press; 1993.Google Scholar
Shoham, Z, Conway, GS, Patel, A, Jacobs, HS. Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome. Fertil Steril 1992;58:37–45.CrossRefGoogle ScholarPubMed
Schachter, M, Balen, AH, Patel, A, Jacobs, HS. Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone. Gynecol Endocrinol 1996;10:327–335.CrossRefGoogle ScholarPubMed
Muasher, SJ, Abdallah, RT, Hubayter, ZR. Optimal stimulation protocols for in vitro fertilization. Fertil Steril 2006;86:267–273.Google Scholar
The Practice Committee of the American Society for Reproductive Medicine, Birmingham, Alabama. Gonadotropin preparations: past, present and future perspectives. Fertil Steril 2008;90(5 Suppl):S13–S20.CrossRefGoogle Scholar
Al-Inany, H, Aboulghar, MA, Mansour, RT, Proctor, M. Recombinant versus urinary gonadotrophins for triggering ovulation in assisted conception. Hum Reprod 2006;21:569–570.Google Scholar
Bordewijk, EM, Mol, F, van der Veen, F, Van Wely, M. Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis. Hum Reprod Open 2019;2019(3):hoz008.Google Scholar
van Wely, M, Kwan, I, Burt, AL, et al. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev 2011;2:CD005354.Google Scholar
The Practice Committee of the American Society for Reproductive Medicine. Use of exogenous gonadotropins in anovulatory women: a technical bulletin. Fertil Steril 2008;90(5 Suppl):S7–S12.Google Scholar
Filicori, M, Cognigni, GE, Samara, A, et al. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update 2002;8:543–557.Google Scholar
Krause, BT, Ohlinger, R, Haase, A. Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review. Biologics 2009;3:337–347.Google Scholar
Shoham, Z, Balen, A, Patel, A, Jacobs, HS. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril 1991;56:1048–1053.Google Scholar
O’Dea, L, the US Recombinant Human LH Study Group. Recombinant LH in support of recombinant FSH in female hypogonadotropic hypogonadism-evidence of threshold effect. Fertil Steril 2000;74(Suppl 1):S36.CrossRefGoogle Scholar
Hagen, CP, Sørensen, K, Anderson, RA, Juul, A. Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist. Fertil Steril 2012;98(5):1326–1330.Google Scholar
Sönmezer, M, Özmen, B, Atabekoglu, CS, et al. Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism. J Assist Reprod Genet 2012;29(7):597–602.Google Scholar
Messinis, IE. Ovulation induction: a mini review. Hum Reprod 2005;20:2688–2697.CrossRefGoogle ScholarPubMed
Messinis, IE, Bergh, T, Wide, L. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility. Fertil Steril 1988;50(1):31–35.CrossRefGoogle ScholarPubMed
Van der Linden, M, Buckingham, K, Farquhar, C, Kremer, JA, Metwally, M. Luteal phase support in assisted reproduction cycles. Hum Reprod Update 2012;18(5):473.Google Scholar
Aboulghar, M. Luteal support in reproduction: when, what and how? Curr Opin Obstet Gynecol 2009;21:279–284.Google Scholar
Kaufmann, R, Dunn, R, Vaughn, T, et al. Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women. Clin Endocrinol (Oxf) 2007;67:563–569.Google Scholar
Shoham, Z, Smith, H, Yeko, T, et al. Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study. Clin Endocrinol (Oxf) 2008;69:471–478.Google Scholar
Loumaye, E, Engrand, P, Shoham, Z, Hillier, SG, Baird, DT. Clinical evidence for an LH ‘ceiling’ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod 2003;18(2):314–322.CrossRefGoogle Scholar
Awwad, JT, Farra, C, Mitri, F, et al. Split daily recombinant human LH dose in hypogonadotrophic hypogonadism: a nonrandomized controlled pilot study. Reprod Biomed Online 2013;26(1):88–92.Google Scholar
le Cotonnec, JY, Loumaye, E, Porchet, H, Beltrami, V, Munafo, A. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. Fertil Steril 1998;69(2):201–209.Google Scholar
Balasch, J, Fábregues, F, Carmona, F, Casamitjana, R, Tena-Sempere, M. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2009;94:2367–2373.CrossRefGoogle ScholarPubMed
Fluker, MR, Urman, B, Mackinnon, M, et al. Exogenous gonadotropin therapy in World Health Organization groups I and II ovulatory disorders. Obstet Gynecol 1994;83:189–196.Google Scholar
Tadokoro, N, Vollenhoven, B, Clark, S, et al. Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction programme. Hum Reprod 1997;12:1939–1944.Google Scholar
Kumbak, B, Kahraman, S. Women with hypogonadotropic hypogonadism: cycle characteristics and results of assisted reproductive techniques. Acta Obstet Gynecol Scand 2006;85:1453–1457.Google Scholar
Ghaffari, F, Arabipoor, A, Lankarani, NB, Etminan, Z, Tehraninejad, ES. Assisted reproductive technique outcomes in hypogonadotropic hypogonadism women. Ann Saudi Med 2013;33(3):235–240.Google Scholar
Pandurangi, M, Tamizharasi, M, Reddy, NS. Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism. J Hum Reprod Sci 2015;8(3):146–150.CrossRefGoogle ScholarPubMed
Yilmaz, S, Ozgu-Erdinc, AS, Yumusak, O, et al. The reproductive outcome of women with hypogonadotropic hypogonadism undergoing in vitro fertilization. Syst Biol Reprod Med 2015;61(4):228–232.CrossRefGoogle ScholarPubMed
Mumusoglu, S, Ata, B, Turan, V, et al. Does pituitary suppression affect live birth rate in women with congenital hypogonadotrophic hypogonadism undergoing intra-cytoplasmic sperm injection? A multicenter cohort study. Gynecol Endocrinol 2017;33(9):728–732.Google Scholar
Cecchino, GN, Canillas, GM, Cruz, M, García-Velasco, JA. Impact of hypogonadotropic hypogonadism on ovarian reserve and response. J Assist Reprod Genet 2019;36(11):2379–2384.Google Scholar
Kuroda, K, Ezoe, K, Kato, K, et al. Infertility treatment strategy involving combined freeze‐all embryos and single vitrified‐warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism. J Obstet Gynaecol Res 2018;44(5):922–928.Google Scholar
Klemetti, R, Sevon, T, Gissler, M, Hemm, E. Complications of IVF and ovulation induction. Hum Reprod 2005;20:3293–3300.CrossRefGoogle ScholarPubMed
Aboulghar, M. Symposium: Update on prediction and management of OHSS. Prevention of OHSS. Reprod Biomed Online 2009;19:33–42.CrossRefGoogle ScholarPubMed
The Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 2008;90(5 Suppl):S188–S193.Google Scholar
Mathur, R, Kailasam, C, Jenkins, J. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil 2007;10:75–85.Google Scholar
Letterie, GS, Coddington, CC, Collins, RL, Merriam, GR. Ovulation induction using s.c. pulsatile gonadotrophin-releasing hormone: effectiveness of different pulse frequencies. Hum Reprod 1996;11:19–22.Google Scholar
Homburg, R, Eshel, A, Armar, NA, et al. One hundred pregnancies after treatment with pulsatile luteinizing hormone releasing hormone to induce ovulation. Br Med J 1989;298:809–812.Google Scholar
Braat, DD, Ayalon, D, Blunt, SM, et al. Pregnancy outcome in luteinizing hormone-releasing hormone induced cycles: a multicentre study. Gynecol Endocrinol 1989;3:35–44.Google Scholar
Martin, KA, Hall, JE, Adams, JM, Crowley, WF Jr. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 1993;77(1):125–129.Google Scholar
Mattle, V, Leyendecker, G, Wildt, L. Side effects of pulsatile GnRH therapy for induction of ovulation. Expert Rev Endocrinol Metab 2008;3:535–538.Google Scholar
Filicori, M, Flamigni, C, Dellai, P, et al. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 1994;79(4):1215–1220.Google Scholar
Hall, R, Manski-Nankervis, J, Goni, N, Davies, MC, Conway, GS. Fertility outcomes in women with hypopituitarism. Clin Endocrinol 2006;65:71–74.Google Scholar
Hull, KL, Harvey, S. Growth hormone: roles in female reproduction. J Endocrinol 2001;168:1–23.Google Scholar
Park, JK, Murphy, AA, Bordeaux, BL, Dominguez, CE, Session, DR. Ovulation induction in a poor responder with panhypopituitarism: a case report and review of the literature. Gynecol Endocrinol 2007;23:82–86.Google Scholar
Homburg, R, West, C, Torresani, T, Jacobs, HS. Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial. Fertil Steril 1990;53:254–260.Google Scholar
Giampietro, A, Milardi, D, Bianchi, A, et al. The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature. Fertil Steril 2009;91(3):930.e7–930.e11.Google Scholar
Daniel, A, Ezzat, S, Greenblatt, E. Adjuvant growth hormone for ovulation induction with gonadotropins in the treatment of a woman with hypopituitarism. Case Rep Endocrinol 2012;20:12.Google Scholar
Salle, A, Klein, M, Pascal-Vigneron, V, et al. Successful pregnancy and birth after sequential cotreatment with growth hormone and gonadotropins in a woman with panhypopituitarism: a new treatment protocol. Fertil Steril 2000;74:1248–1250.Google Scholar
Harper, K, Proctor, M, Hughes, E. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev 2003;3:CD000099.Google Scholar
Jacobs, HS, Shoham, Z, Schachter, M, et al. Cotreatment with growth-hormone and gonadotropin for ovulation induction in hypogonadotropic patients-a prospective, randomized, placebo-controlled, dose-response study. Fertil Steril 1995;64(5):917–923.Google Scholar
Curran, AJ, Peacey, SR, Shalet, SM. Is maternal growth hormone essential for a normal pregnancy? Eur J Endocrinol 1998;139:54–58.Google Scholar
Menashe, Y, Sack, J, Mashiach, S. Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation? Hum Reprod 1991;6:670–671.Google Scholar
Voutetakis, A, Sertedaki, A, Livadas, S, et al. Ovulation induction and successful pregnancy outcome in two patients with Prop1 gene mutations. Fertil Steril 2004;82:454–457.Google Scholar
Yildirim, M, Noyan, V, Tiras, MB. Estrogen-progestagen pre-treatment before HMG induction in hypogonadotropic patients. Int J Gynaecol Obstet 2000;71:249–250.Google Scholar
Hayashi, M, Tomobe, K, Hoshimoto, K, Ohkura, T. Successful pregnancy following gonadotropin therapy in a patient with hypogonadotropic hypogonadism resulting from craniopharyngioma. Int J Clin Pract 2002;56:149–151.Google Scholar
Toumba, M, Sergis, A, Kanaris, C, Skordis, N. Endocrine complications in patients with thalassaemia major. Pediatr Endocrinol Rev 2007;5:642–648.Google Scholar
Chatterjee, R, Bajoria, R. Critical appraisal of growth retardation and pubertal disturbances in thalassemia. Ann N Y Acad Sci 2010;1202(1):100–114.Google Scholar
Poggi, M, Sorrentino, F, Pugliese, P, et al. Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years. Ann Hematol 2016;95(5):757–763.CrossRefGoogle ScholarPubMed
Pafumi, C, Farina, M, Pernicone, G, et al. At term pregnancies in transfusion-dependent beta-thalassemic women. Clin Exp Obstet Gynecol 2000;27:185–187.Google Scholar
Skordis, N, Christou, S, Koliou, M, Pavlides, N, Angastiniotis, M. Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab 1998;11(Suppl 3):935–943.Google Scholar
Karagiorga-Lagana, M. Fertility in thalassemia: the Greek experience. J Pediatr Endocrinol Metab 1998;11(Suppl 3):945–951.Google ScholarPubMed
Cunningham, MJ, Macklin, EA, Muraca, G, Neufeld, EJ. Successful pregnancy in thalassemia major women in the Thalassemia Clinical Research Network. Pediatr Res 2004;55:294A.Google Scholar
Tuck, SM. Fertility and pregnancy in thalassemia major. Ann N Y Acad Sci 2005;1054:300–307.Google Scholar
Bajoria, R, Chatterjee, R. Current perspectives of fertility and pregnancy in thalassemia. Hemoglobin 2009;33(Suppl 1):S131–S135.Google Scholar
Origa, R, Piga, A, Quarta, G, et al. Pregnancy and β-thalassemia: an Italian multicenter experience. Haematologica 2010;95(3):376–381.Google Scholar
Dungan, HM, Clifton, DK, Steiner, RA. Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion. Endocrinology 2006;147:1154–1158.Google Scholar
Lee, JH, Miele, ME, Hicks, DJ, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996;88:1731–1737.Google Scholar
Tena-Sempere, M. Kisspeptin signaling in the brain: recent developments and future challenges. Mol Cell Endocrinol 2010;314:164–169.Google Scholar
Reynolds, RM, Logie, JJ, Roseweir, AK, McKnight, AJ, Millar, RP. A role for kisspeptins in pregnancy: facts and speculations. Reproduction 2009;138:1–7.Google Scholar
Thompson, EL, Patterson, M, Murphy, KG, et al. Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 2004;16:850–858.Google Scholar
Dhillo, WS, Chaudhri, OB, Thompson, EL, et al. Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab 2007;92:3958–3966.Google Scholar
Roa, J, Aguilar, E, Dieguez, C, Pinilla, L, Tena-Sempere, M. New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Front Neuroendocrinol 2008;29:48–69.Google Scholar
Dekel, N. Master regulators of female infertility. N Engl J Med 2009;361:718–719.Google Scholar
Fan, HY, Liu, Z, Shimada, M, et al. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science 2009;324:938–941.Google Scholar
Xekouki, P, Tolis, G. Ovulation induction for hypogonadotropic hypogonadism. In: Aboulghar, M, Rizk, B, eds. Ovarian Stimulation. Cambridge: Cambridge University Press; 2011:162–172.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×